Documente Academic
Documente Profesional
Documente Cultură
1
1
2
2
3
4
5
5
6
6
6
6
7
7
8
9
9
9
10
11
12
13
14
15
16
16
17
17
18
18
18
19
20
21
22
23
23
23
24
25
25
26
27
28
28
28
29
30
31
31
31
31
31
32
33
1
1
1
2
2
3
4
5
5
6
6
6
6
7
7
8
9
9
10
11
11
12
12
12
13
13
13
1
1
2
2
2
3
4
4
5
5
6
7
7
7
8
9
10
11
11
12
12
1019
1019
1019
685
685
624
684
625
625
618
618
618
618
619
619
621
103
103
103
1000
7
3
9
17
139
14
14
601
601
115
115
115
116
1011
1009
1008
124
124
124
128
627
627
137
1033
120
120
120
606
400
401
401
401
401
401
406
407
1024
110
51
15
1000
1009
1009
25
1010
1012
1016
1016
33
31
1018
1018
1015
1019
38
1022
1022
403
403
403
711
711
711
3014
3014
619
619
619
1
631
631
624
624
634
700
700
700
613
610
650
11
11
18
18
48
48
48
65
65
35
55
41
41
51
51
51
51
66
66
21
72
72
72
50
41
61
86
45
78
16
16
22
22
42
42
42
62
61
45
91
73
73
73
58
24
24
86
86
28
28
28
61
72
19
19
19
19
19
46
69
73
91
51
16
15
10
10
21
54
17
40
40
44
74
37
37
20
38
0
55
55
33
33
33
21
21
21
84
84
81
81
81
54
51
51
60
60
76
89
89
89
53
70
33
45
45
45
45
T3T
2.10 >>>
1.30 - 2.6
nmol/L
T4T
8.52 >>>
4.80 - 12.7
g/dL
HIERRO
38.12 >>>
37 - 145
ug/dL
T3T
1.85 >>>
1.30 - 2.6
nmol/L
T4T
6.03 >>>
4.80 - 12.7
g/dL
IgE
1277.3 >>>
0 - 1 ao 0.0 - 15.0; 1 - 5 a UI/mL
T3L
2.78 >>>
1.8 - 4.2
pg/mL
INS
7.59 OBSERV. BASAL2.6 - 24.9
uU/ml
INS
27.56 OBSERV. POSTP22.00 - 79.00
uU/ml
(Na+)
138 >>>
135.0 - 148.0
mmol/L
(K+)
4.1 >>>
3.5 - 5.3
mmol/L
(Cl-)
102 >>>
98.0 - 106.0
mmol/L
HbA1C
14.80 >>>
0.0 - 6.0
%
T3T
1.91 >>>
1.30 - 2.6
nmol/L
T4T
9.52 >>>
4.80 - 12.7
g/dL
Anti-HBcAg
0.06 NO REACTIVO NO REACTIVO: > 1.0; REACTCOI
HbA1C
6.00 >>>
0.0 - 6.0
%
T3T
1.56 >>>
1.30 - 2.6
nmol/L
T4T
5.04 >>>
4.80 - 12.7
g/dL
T3L
2.24 >>>
1.8 - 4.2
pg/mL
HbA1C
6.10 >>>
0.0 - 6.0
%
NEGATIVO: 00.0 - 13.0;
mAlb
6.70 OBSERV. ORINA0.0 - 30.0
mg/24 hor
INDETERMINADO: 13.0 PCR_NFL
38.56 >>>
0.0 - 10.0
mg/L
20.0;
POSITIVO: 20.0 INS
16.22 OBSERV. BASAL2.6
24.9
uU/ml
50.0;- POSITIVO
FUERTE:
HP_M
10.20 >>>
Mayor de 50.0
uIU/mL
T3L
2.26 >>>
1.8 - 4.2
pg/mL
HbA1C
5.20 >>>
0.0 - 6.0
%
Anti-HBcAg
1.33 NO REACTIVO NO REACTIVO: > 1.0; REACTCOI
Anti-HBc IgM
0.74 NO REACTIVO 0.0 - 1.0
COI
CA125
17.37 >>>
Negativo : < 35.0; Sospecho
U/mL
AFP
2.70 >>>
0,0 5,5
IU/mL
CEA
1.76 >>>
No fumadores 0 - 5; fumadong/mL
HbA1C
5.90 >>>
0.0 - 6.0
%
VB12
1285.57 >>>
200 - 1000
pg/mL
INS
16.22 OBSERV. BASAL2.6 - 24.9
uU/ml
HbA1C
9.10 >>>
0.0 - 6.0
%
HbA1C
5.40 >>>
0.0 - 6.0
%
T3T
2.17 >>>
1.30 - 2.6
HOMBRES
: ND - nmol/L
56
T4T
10.12 >>>
4.80 - 12.7
g/dL
MUJERES
HbA1C
9.20 >>>
0.0 - 6.0 >>>
%
postmenop.
NO
TTO.
:
TTE
3.16 >>>
Hombres: 2.7 - 107 Mujeresng/mL
ND - 30
: 0.8
HOMBRES
TTE_F
189.20 >>>
Varones: 90 - 300;: 0.7
Mujeres:
pg/mL
Tratadas :
-postmenop
7.6
11.1
VB12
959.27 >>>
200
1000
pg/mL
ND --93
Ciclo
Ovulatorio>>>
MUJERES.
HbA1C
12.29 >>>
0.0
6.0
anticonceptivos
Orales: 1.1 %
Fase- folicular
Menstruacin
normal.
-folicular
102
Anti-HBcAg
1.56 NEGATIVO
NO
REACTIVO:
> :1.0;
COI
-:ND
11.6
Fase
2.8 REACT
Ciclos
ovulatorios:
Ciclo
Medio
: 17
TOXO_M
0.08 NO REACTIVO 11.3
NO REACTIVE
< 0.8 INDETECOI
Fase
folicular
:ND
-NO
77
F.
Folicular
2-3d
: 3.0 TOXO_G
15.40 REACTIVO
REACTIVE
< 1.0 INDETECOI
- 160ltea
Fase
: ND %
14.4
HbA1C
7.70 >>>
0.0 - 6.0
Fase
das
2 -a21
3:
- 14.7folicular
Ciclo
Medio
:
5.8
HbA1C
11.00 >>>
0.0 -- 84;
6.0 Periovulatorio 3 %
ND
Perimenstrual
8
d.
:
Fase Ltea
: 1.2 - 9.0
CA125
23.09 >>>
Negativo
:
<
35.0;
Sospecho
U/mL
dias:
34 - 400; Fase Lutea:
ND
- 12.0
Postmenopasicas
:
E2
75.70 >>>
27
246
pg/mL
Postmenopasicas
:
21.7
- 153
LH
6.18 >>>
11.3-39.8 orales
Anticoncep.
:ND mIU/mL
FSH
2.55 >>>
mIU/mL
PRL
24.49 >>>
Hombres: 2.7 - 16.9; Mujere
ng/mL
PAULL BUNNELL NEGATIVO
HbA1C
12.50 >>>
0.0 - 6.0
%
HbA1C
7.10 >>>
0.0 - 6.0
%
VB12
679.96 >>>
200 - 1000
pg/mL
WALER ROSSE
19.10 >>>
0.0 - 32.0
IU/mL
PRL
28.81 pool prolactina Hombres: 2.7 - 16.9; Mujere
ng/mL
VB12
743.22 >>>
200 - 1000
pg/mL
INS
20.62 OBSERV. BASAL2.6 - 24.9
uU/ml
INS
73.85 OBSERV. POSTP22.00 - 79.00
uU/ml
PRL
105.46 >>>
Hombres: 2.7 - 16.9; Mujere
ng/mL
ANTI HAV_M
0.13 OBSERV. METO NO REACTIVE < = 2.0 RE COI
PRL
22.65 >>>
Hombres: 2.7 - 16.9; Mujere
ng/mL
T3T
1.96 >>>
1.30 - 2.6
nmol/L
T4T
9.20 >>>
4.80 - 12.7
g/dL
HbA1C
12.50 >>>
0.0 - 6.0
%
HbA1C
9.30 >>>
0.0 - 6.0
%
HOMBRES
:
0.8
HOMBRES
:
0.7
T3T
1.83 >>>
1.30 - 2.6
nmol/L
- 7.6
11.1
T4T
8.51 >>>
4.80 - 12.7
g/dL
Ciclo
Ovulatorio>>>
MUJERES.
PCR_NFL
4.34 >>>
0.0 - folicular
10.0
mg/L
Fase
Menstruacin
normal. : 1.1
B2M
1.9 >>>
0.67
2.14
mg/L
- 11.6folicular
Fase
: 2.8 Ciclo
Medio
:
17
IgE
45.4 >>>
0
1
ao
0.0
15.0;
1
5
a
UI/mL
11.3
-0.0
77
F.
Folicular
: 3.0 - IU/mL
ANTI TG
96.30 >>>
- 115.0 2-3d
Fase
: ND IU/mL
14.4
ANTI TPO
17.03
0.0 - ltea
34.0
- 14.7Medio
Ciclo
: 5.8 - 21
ANTI TG
102.80 >>>
0.0 - 115.0
IU/mL
Perimenstrual
8 d.- 9.0
:
Fase
Ltea
: 1.2
ANTI TPO
39.20
0.0 -- 12.0
34.0
IU/mL
ND
Postmenopasicas :
T3T
1.46 >>>
1.30 -- 2.6
nmol/L
Postmenopasicas
:
21.7
153
LH
5.27 >>>
11.3-39.8 orales
Anticoncep.
:ND mIU/mL
FSH
5.08 >>>
mIU/mL
CORT am
16.30 >>>
4.30 - 22.40
ug/dL
CPKMB
13
0.0 - 25.0
U/L
cTnT
0.01 >>>
0.0 - 0.2
ng/mL
VB12
349.78 >>>
200 - 1000
pg/mL
T3L
2.05 >>>
1.8 - 4.2
pg/mL
PSAF
0.41 >>>
0 - 40 : 0.0 - 0.33, 40 - 49 ng/mL
HbA1C
5.40 >>>
0.0 - 6.0
%
PCR_NFL
6.40 >>>
0.0
- 10.0
HOMBRES
: ND - mg/L
56
B2M
1.89 >>>
0.67 - 2.14
mg/L
MUJERES
T3L
3.92 >>>
1.8 - 4.2 >>>
pg/mL
postmenop.
NO
TTO.
:
HOMBRES
: 0.7 WALER ROSSE
56.90 >>>
0.0 - 32.0
IU/mL
ND - 30
11.1
VB12
467.8 >>>
200 - 1000
pg/mL
postmenop Tratadas :
MUJERES.
(Na+)
133 >>>
135.0
- 148.0
mmol/L
ND
- 93
Menstruacin
normal.
(K+)
4.9 >>>
3.5 - folicular
5.3
mmol/L
anticonceptivos
Orales
Fase
: 2.8 :ND
(Cl-)
96 >>>
98.0--102
106.0
mmol/L
11.3
Ciclos
ovulatorios:
F.
Folicular
2-3d
: 3.0 - pg/mL
T3L
2.14 >>>
1.8
- 4.2
Fase
:ND %
14.4
HbA1C
5.70 >>>
0.0 - folicular
6.0
-Ciclo
160 Medio
: 5.8 - 21
HbA1C
4.80 >>>
0.0 - 6.0
%
Fase Ltea
folicular das
2 -a9.0
3:
Fase
: 1.2
HbA1C
6.30 >>>
0.0
6.0 Periovulatorio 3 %
ND -- 84;
Postmenopasicas
:
INS
22.16 OBSERV. BASAL2.6
24.9
dias:--34
- 400; Fase Lutea: uU/ml
21.7
153
E2
85.02 >>>
27 - 246
Anticoncep.
orales
:ND pg/mL
FSH
1.62 >>>
mIU/mL
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/27/2014
10/28/2014
10/28/2014
10/28/2014
10/28/2014
10/28/2014
10/28/2014
10/28/2014
10/28/2014
10/28/2014
10/28/2014
10/28/2014
10/28/2014
10/28/2014
10/28/2014
10/28/2014
10/28/2014
10/28/2014
10/28/2014
10/28/2014
10/28/2014
10/28/2014
10/28/2014
10/28/2014
10/28/2014
10/28/2014
10/28/2014
10/29/2014
10/29/2014
10/29/2014
10/29/2014
10/29/2014
10/29/2014
10/29/2014
10/29/2014
10/29/2014
10/29/2014
10/29/2014
10/29/2014
10/29/2014
10/29/2014
10/29/2014
10/29/2014
10/29/2014
10/29/2014
10/29/2014
10/29/2014
10/29/2014
10/29/2014
13
14
14
15
16
17
18
19
20
1
2
3
3
3
3
4
5
5
6
6
6
7
7
7
8
9
10
10
10
11
12
13
14
15
16
17
18
19
19
20
21
21
1
1
1
2
3
4
5
6
7
7
8
8
8
7
8
8
9
9
9
10
10
11
12
12
12
13
13
13
14
14
15
16
16
17
17
17
17
17
18
18
19
20
21
22
23
23
24
24
25
25
25
26
27
27
28
29
1
2
3
3
3
3
104
404
404
405
415
421
421
667
3055
3006
638
1016
1016
1016
1016
25
111
111
3000
3000
3000
621
621
621
617
602
105
105
105
6
11
2
1000
600
124
1021
407
418
418
420
1042
1042
116
116
116
700
116
3011
1017
1005
1000
1000
609
609
609
618
619
619
621
621
621
629
629
628
102
102
102
105
105
105
107
107
111
112
112
1019
1019
1019
1019
1019
3009
3009
115
602
106
632
3014
3014
401
401
406
406
406
407
413
413
122
103
652
32
3005
3005
3005
3005
27
27
57
51
67
36
36
36
36
38
81
81
63
63
63
53
53
53
76
45
87
87
87
64
68
44
74
74
20
33
86
53
53
56
27
27
46
46
46
69
46
86
52
81
37
37
88
88
88
9
9
9
16
16
16
46
46
78
83
83
83
18
18
18
30
30
80
51
51
85
85
85
85
85
73
73
40
49
79
67
48
48
47
47
67
67
67
68
5
5
13
74
39
92
27
27
27
27
T3L
2.09
CPKTOTAL
96
DHL
346.40
HbA1C
5.90
PRL
30.95
IgE
91.6
IgE
73.8
PRL
10.83
cTnT
0.29
HbA1C
10.80
T3L
2.14
LH
6.01
FSH
8.00
TTE_F
10.20
DHEAS
256.70
T3L
2.05
VB12
304.5
T3L
2.72
T3L
2.65
CA125
17.37
CA15.3
3.25
T3L
3.32
VB12
467.8
HbA1C
6.10
T3L
3.68
PCR_NFL
39.67
T3L
2.13
VB12
566.78
PSAF
2.19
VB12
367.8
T3L
3.48
HbA1C
5.04
FOSFORO
4.23
PCR_NFL
28.40
FTA_ABS
NEGATIVO
T3L
3.01
HbA1C
6.90
T3T
1.98
T4T
9.10
HbA1C
8.40
T3T
1.87
T4T
8.35
CPKTOTAL
1759
DHL
338.0
WALER ROSSE
16.79
PSAF
0.12
T3L
2.40
FR_NFL
21.40
WALER ROSSE
9.08
TTE
2.62
T3T
1.68
T4T
6.34
(Na+)
133
(K+)
4.9
(Cl-)
97
ASO_NFL
100
T3T
1.98
T4T
10.04
(Na+)
138
(K+)
4.7
(Cl-)
102
B2M
1.93
DHL
341.60
T3L
1.66
(Na+)
134
(K+)
4.9
(Cl-)
99
LH
22.17
FSH
36.55
PRL
11.94
WALER ROSSE
21.34
ANA
NEGATIVO
CARBAMAZEPINA
4.60
T3L
2.24
HbA1C
4.90
HbA1C
5.60
FR_NFL
3.67
WALER ROSSE
24.10
ANA
NEGATIVO
PCR_NFL
19.80
T3L
2.49
VB12
466.7
IgE
70.9
HbA1C
6.90
HbA1C
6.70
HbA1C
7.10
HP_G
27.80
HP_M
11.20
IgE
668.0
CORT am
6.34
HbA1C
5.90
T3T
2.10
T4T
9.80
HbA1C
5.70
T3T
1.97
T4T
10.12
ASO_NFL
130
PSAF
1.11
IgE
59.5
HbA1C
7.70
INS
23.04
E2
81.10
FSH
5.96
PRL
14.62
>>>
1.8 - 4.2
pg/mL
: 0.8
HOMBRES
: 0.7
60.0 - 219
U/L
-11.1
7.6
>>>
200 - 480
U/L
Ciclo Ovulatorio>>>
MUJERES.
>>>
0.0
6.0
%
Fase- folicular
Menstruacin
normal. : 1.1
pool prolactina -Hombres:
2.7 - 16.9;
ng/mL
11.6folicular
Fase
: 2.8 Mujere
Ciclo
Medio
>>>
0 - 1 ao
0.0 - 15.0; 1:-17
5 a UI/mL
11.3
-0 77
F.
2-3d
>>>
-Folicular
1 ao 0.0
- 15.0; 1: 3.0
- 5 a- UI/mL
Fase
ltea 2.7 - 16.9; :Mujere
ND ng/mL
14.4
>>>
Hombres:
- 14.7Medio
Ciclo
:
5.8
21
>>>
0.0 - 0.2
ng/mL
Perimenstrual
8
d.
:
Fase Ltea
: 1.2 - 9.0
>>>
0.0
6.0
%
ND -- 12.0
Postmenopasicas
:
>>>
1.8
4.2
pg/mL
Postmenopasicas
:
21.7
- 153
>>>
11.3-39.8 orales
Anticoncep.
:ND mIU/mL
>>>
mIU/mL
>>>
Varones: 90 - 300; Mujeres:pg/mL
AOS
>>>
1.8 - 4.2
pg/mL
>>>
200 - 1000
pg/mL
>>>
1.8 - 4.2
pg/mL
>>>
1.8 - 4.2
pg/mL
>>>
Negativo : < 35.0; Sospecho
U/mL
>>>
Negativo: < 30.0; SospechosU/mL
>>>
1.8 - 4.2
pg/mL
>>>
200 - 1000
pg/mL
>>>
0.0 - 6.0
%
>>>
1.8 - 4.2
pg/mL
>>>
0.0 - 10.0
mg/L
>>>
1.8 - 4.2
pg/mL
>>>
200 - 1000
pg/mL
>>>
0 - 40 : 0.0 - 0.33, 40 - 49 ng/mL
>>>
200 - 1000
pg/mL
>>>
1.8 - 4.2
pg/mL
>>>
0.0 - 6.0
%
>>>
2.5 - 5.6
mg/dL
>>>
0.0 - 10.0
mg/L
>>>
>>>
>>>
>>>
1.8 - 4.2
pg/mL
>>>
0.0 - 6.0
%
>>>
1.30 - 2.6
nmol/L
>>>
4.80 - 12.7
g/dL
>>>
0.0 - 6.0
%
>>>
1.30 - 2.6
nmol/L
>>>
4.80 - 12.7
g/dL
60.0 - 219
U/L
>>>
200 - 480
U/L
>>>
0.0 - 32.0
IU/mL
>>>
0 - 40 : 0.0 - 0.33, 40 - 49 ng/mL
>>>
1.8 - 4.2
pg/mL
>>>
0.0 - 6.0
IU/L
>>>
0.0 - 32.0
IU/mL
>>>
Hombres: 2.7 - 107 Mujeresng/mL
>>>
1.30 - 2.6
nmol/L
>>>
4.80 - 12.7
g/dL
>>>
135.0 - 148.0
mmol/L
>>>
3.5 - 5.3
mmol/L
>>>
98.0 - 106.0
mmol/L
>>>
0.0 - 200.0
IU/mL
>>>
1.30 - 2.6
nmol/L
: 0.8
HOMBRES
: 0.7
>>>
4.80 - 12.7
g/dL
-11.1
7.6
>>>
135.0 - 148.0
mmol/L
Ciclo Ovulatorio>>>
MUJERES.
>>>
3.5
5.3
mmol/L
Fase- folicular
Menstruacin
normal. : 1.1
>>>
106.0
mmol/L
-98.0
11.6-folicular
Fase
: 2.8 Ciclo
: 17 mg/L
>>>
0.67 -Medio
2.14
11.3
-200
77
F.
Folicular
: 3.0 - U/L
>>>
- 480 2-3d
Fase
: ND pg/mL
14.4
>>>
1.8 - ltea
4.2
- 14.7Medio
Ciclo
:
5.8
21
>>>
135.0 - 148.0
mmol/L
Perimenstrual
8
d.
:
Fase Ltea
: 1.2 - 9.0
>>>
3.5
5.3
mmol/L
ND -- 12.0
Postmenopasicas
:
>>>
98.0
106.0
mmol/L
Postmenopasicas
:
21.7
- 153
>>>
11.3-39.8 orales
Anticoncep.
:ND mIU/mL
>>>
mIU/mL
>>>
Hombres: 2.7 - 16.9; Mujere
ng/mL
>>>
0.0 - 32.0
IU/mL
OBSERV. Metodo
NEGATIVO < 1/100; POSITIV>>>
4.0 - 10.0
ug/mL
>>>
1.8 - 4.2
pg/mL
>>>
0.0 - 6.0
%
>>>
0.0 - 6.0
%
>>>
0.0 - 6.0
IU/L
>>>
0.0 - 32.0
IU/mL
OBSERV. Metodo
NEGATIVO < 1/100; POSITIV>>>
>>>
0.0 - 10.0
mg/L
>>>
1.8 - 4.2
pg/mL
>>>
200 - 1000
pg/mL
>>>
0 - 1 ao 0.0 - 15.0; 1 - 5 a UI/mL
NEGATIVO: 00.0 - 13.0;
>>>
0.0 - 6.0
%
INDETERMINADO:
13.0 NEGATIVO:
00.0 - 13.0;
>>>
0.0
- 6.0
%
20.0;
POSITIVO: 20.0
INDETERMINADO:
13.0- >>>
0.0 - 6.0
%
50.0;
POSITIVO FUERTE:
20.0;
POSITIVO:
20.0 >>>
MayorPOSITIVO
de 50.0 FUERTE:
uIU/mL
50.0;
>>>
Mayor de 50.0
uIU/mL
>>>
0 - 1 ao 0.0 - 15.0; 1: ND
- 5 a- UI/mL
HOMBRES
56
>>>
4.30 - 22.40
ug/dL
MUJERES
>>>
0.0 - 6.0 >>>
%
postmenop.
HOMBRES
: 0.7 :>>>
1.30 - 2.6 NO TTO.
nmol/L
ND - 30
11.1
>>>
4.80 - 12.7
g/dL
postmenop Tratadas :
MUJERES.
>>>
0.0 -- 93
6.0
%
ND
Menstruacin normal.
>>>
1.30 -folicular
2.6
nmol/L
anticonceptivos
Orales
Fase
: 2.8 :ND
>>>
4.80--102
12.7
g/dL
11.3
Ciclos
ovulatorios:
F.
Folicular
: 3.0 - IU/mL
>>>
0.0
- 200.0 2-3d
Fase
14.4
>>>
0 - 40folicular
: 0.0 - 0.33, 40 -:ND
49 ng/mL
-Ciclo
160 Medio
: 5.8 -121
>>>
0 - 1 ao
0.0 - 15.0;
- 5 a UI/mL
Fase Ltea
folicular das
2 -a9.0
3:
Fase
: 1.2
>>>
0.0
6.0 Periovulatorio 3 %
ND -- 84;
Postmenopasicas
:
OBSERV. BASAL2.6
24.9
dias:
- 400; Fase Lutea: uU/ml
21.7--34
153
>>>
27 - 246
Anticoncep.
orales
:ND pg/mL
>>>
mIU/mL
>>>
Hombres: 2.7 - 16.9; Mujere
ng/mL
10/29/2014
10/29/2014
10/29/2014
10/29/2014
10/29/2014
10/29/2014
10/29/2014
10/29/2014
10/29/2014
10/30/2014
10/30/2014
10/30/2014
10/30/2014
10/30/2014
10/30/2014
10/30/2014
10/30/2014
10/30/2014
10/30/2014
10/30/2014
10/30/2014
10/30/2014
10/30/2014
10/30/2014
10/30/2014
10/30/2014
10/30/2014
10/30/2014
10/30/2014
10/30/2014
10/30/2014
10/30/2014
10/30/2014
10/30/2014
10/30/2014
10/30/2014
10/30/2014
10/30/2014
10/30/2014
10/30/2014
10/30/2014
10/30/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/31/2014
10/30/2014
11/3/2014
11/3/2014
11/3/2014
11/3/2014
11/3/2014
11/3/2014
3
3
4
4
5
6
6
7
7
8
9
10
11
12
13
13
13
13
14
14
14
15
16
16
17
18
19
20
21
21
22
23
1
1
1
1
2
2
2
3
4
5
5
6
7
8
8
10
10
10
10
11
12
12
12
13
14
15
16
17
18
18
19
20
21
22
23
24
25
25
25
26
27
27
28
29
30
30
30
31
31
5
5
5
1
1
1
2
3
3
3
3
3
3
4
4
5
5
5
5
6
6
6
7
3005
3005
649
649
648
56
56
507
507
658
3007
38
632
500
42
42
42
42
23
23
23
605
10
10
6
609
611
407
402
402
406
414
1020
1020
1020
1020
1018
1018
1018
27
3
6
1012
25
1008
34
34
613
613
613
613
607
601
601
601
604
612
1027
3019
3018
3016
3016
3014
3013
3009
3003
3001
3000
633
633
633
627
626
626
3024
3025
404
404
404
415
415
14
14
14
29
29
29
620
41
41
41
41
41
41
39
39
1021
1021
1021
1021
614
614
614
35
27
27
18
18
53
55
55
61
61
64
59
84
76
75
47
47
47
47
87
87
87
56
84
84
50
62
72
86
58
58
62
18
85
85
85
85
21
21
21
43
63
42
67
54
62
53
53
95
95
95
95
76
33
33
33
52
61
73
56
12
79
79
60
56
70
31
52
48
58
58
58
61
67
67
87
34
41
41
41
38
38
68
68
68
69
69
69
22
20
20
20
20
20
20
45
45
32
32
32
32
50
50
50
86
TTE
0.89 >>>
Hombres: 2.7 - 107 Mujeresng/mL
DHEAS
234.60 AOS
HOMBRES
: ND 56
B2M
1.89 >>>
0.67 - 2.14
mg/L
MUJERES
DHL
318.50 >>>
200 - 480>>>
U/L
postmenop.
TTO.
HOMBRES
: 0.7
IgE
450.2 >>>
0 - 1 ao 0.0NO
- 15.0;
1 -:-5 a UI/mL
ND - 30
11.1
WALER ROSSE
78.90 >>>
0.0 - 32.0
IU/mL
postmenop Tratadas :
MUJERES.
ANA
POSITIVO PAT OBSERV. Metodo
NEGATIVO
< 1/100; POSITIV>>>
ND
- 93
Menstruacin
normal.: 0.8
HOMBRES
FR_NFL
34.60 >>>
0.0 - folicular
6.0
IU/L
anticonceptivos
Orales
Fase
: 2.8 - 7.6
:ND
102
PCR_NFL
6.70 >>>
0.0 --10.0
mg/L
11.3
Ciclo
Ovulatorio>>>
Ciclos
ovulatorios:
F.
Folicular
2-3d
:
3.0
HEPATITIS A TOT
40.98 REACTIVO
0.0
20.0
Fase folicular
: 1.1 UI/L
Fase
folicular
:ND %
14.4
HbA1C
4.90 >>>
0.0
6.0
- 11.6
-Ciclo
160 Medio
: 5.8 - 21
Ciclo
Medio
: 17 %
HbA1C
6.60 >>>
0.0 - 6.0
Fase Ltea
folicular das
2 -a9.0
3:
Fase
: 1.2
-0 77
PSAF
0.26 >>>
- 40
: 0.0
- 0.33, 40 - 49
ND
- 84;
Periovulatorio
3 ng/mL
Postmenopasicas
:: ND
Fase
ltea
PSAF
0.38 >>>
0
40
:
0.0
0.33,
40
49 ng/mL
dias:
34
400;
Fase
Lutea:
-21.7
14.7- 153
E2
155.94 >>>
27 - 246
pg/mL
Anticoncep.
orales
Perimenstrual
8 d. :ND
:
FSH
21.42 >>>
- - 12.0
mIU/mL
ND
PRL
5.50 >>>
Hombres: 2.7 - 16.9; Mujere
ng/mL
Postmenopasicas
:
LH
16 >>>
11.3-39.8
mIU/mL
T3T
1.56 >>>
1.30 - 2.6
nmol/L
T4T
7.89 >>>
4.80 - 12.7
g/dL
VB12
466.89 >>>
200 - 1000
pg/mL
PSAF
0.76 >>>
0 - 40 : 0.0 - 0.33, 40 - 49 ng/mL
T3T
2.10 >>>
1.30 - 2.6
nmol/L
T4T
11.34 >>>
4.80 - 12.7
g/dL
PERFIL DE ALERGIGE 773.40
VER ADJUNTO
HbA1C
8.20 >>>
0.0 - 6.0
%
HbA1C
7.20 >>>
0.0 - 6.0
%
mAlb
4.95 OBSERV. ORINA0.0 - 30.0
mg/24 hor
FR_NFL
2.14 >>>
0.0 - 6.0
IU/L
PCR_NFL
5.32 >>>
0.0 - 10.0
mg/L
HbA1C
6.60 >>>
0.0 - 6.0
%
PCR_NFL
3.90 >>>
0.0 - 10.0
mg/L
VB12
547.4 >>>
200 - 1000
pg/mL
(Na+)
133 >>>
135.0 - 148.0
mmol/L
(K+)
4.8 >>>
3.5 - 5.3
mmol/L
(Cl-)
97 >>>
98.0 - 106.0
mmol/L
ASO_NFL
110 >>>
0.0 - 200.0
IU/mL
IgE
684.70 >>>
0 - 1 ao 0.0 - 15.0; 1 - 5 a UI/mL
T4T
8.40 >>>
4.80 - 12.7
g/dL
INS
7.77 OBSERV. BASAL2.6 - 24.9
uU/ml
HbA1C
13.00 >>>
0.0 - 6.0
%
HbA1C
5.40 >>>
0.0 - 6.0
%
HbA1C
13.40 >>>
0.0 - 6.0
%
HbA1C
5.70 >>>
0.0 - 6.0
%
HbA1C
5.50 >>>
0.0 - 6.0
%
HbA1C
6.40 >>>
0.0 - 6.0
%
mAlb
93.5 OBSERV. ORINA0.0 - 30.0
mg/24 hor
(Na+)
132 >>>
135.0 - 148.0
mmol/L
(K+)
5.0 >>>
3.5 - 5.3
mmol/L
(Cl-)
97 >>>
98.0 - 106.0
mmol/L
FOSFORO
5.06 >>>
2.5 - 5.6
mg/dL
HbA1C
9.20 >>>
0.0 - 6.0
%
FR_NFL
28.60 >>>
0.0 - 6.0
IU/L
PCR_NFL
37.10 >>>
0.0 - 10.0
mg/L
ANA
PATRO HOMOGEOBSERV. Metodo
NEGATIVO < 1/100; POSITIV
HOMBRES
: ND - >>>
56
IgE
930.30 >>>
0 - 1 ao 0.0 - 15.0; 1 - 5 a UI/mL
MUJERES
HbA1C
11.70 >>>
0.0 - 6.0 >>>
%
postmenop.
NO TTO. :
T3L
3.20 >>>
1.8 - 4.2
pg/mL
ND - 30
HbA1C
5.10 >>>
0.0 - 6.0
%
postmenop Tratadas :
ASO_NFL
90 >>>
0.0
200.0
IU/mL
ND -- 93
T3L
2.90 >>>
1.8 - 4.2
pg/mL
anticonceptivos
Orales
:ND
VB12
1300.34 >>>
200 - 102
1000
pg/mL
Ciclos
ovulatorios:
VB12
448.01 >>>
200 - 1000
pg/mL
Fase
folicular
:ND
HbA1C
15.10 >>>
0.0 - 6.0
HOMBRES
: ND - %
- 160
56
PSAF
3.40 >>>
0 - 40 : 0.0 - 0.33, 40 - 49 ng/mL
Fase folicular das 2 a 3:
MUJERES
>>>
T3L
3.05 >>>
1.8
4.2 Periovulatorio
ND -- 84;
3 pg/mL
postmenop.
NO TTO. :
VB12
394.47 >>>
200
1000
dias:- 34
- 400; Fase Lutea: pg/mL
ND
30
HOMBRES
: 0.8
HOMBRES
: 0.7
E2
79.72 >>>
27 - 246
pg/mL
Tratadas :
-postmenop
7.6
11.1
(Na+)
139 >>>
135.0
- 148.0
mmol/L
ND - 93
Ciclo
Ovulatorio>>>
MUJERES.
(K+)
4.1 >>>
3.5 - folicular
5.3
anticonceptivos
Orales: 1.1 mmol/L
Fase
Menstruacin normal.
--folicular
102
(Cl-)
104 >>>
98.0
106.0
mmol/L
-:ND
11.6
Fase
: 2.8 Ciclos
ovulatorios:
Ciclo
Medio
: 17 mg/dL
FOSFORO
3.94 >>>
2.5 - 5.6
11.3
Fase
folicular
:ND
77
F.
Folicular
: 3.0 - pg/mL
VB12
>>>
200
- 1000 2-3d
Mayor de 2000
- 160ltea
Fase
: ND %
14.4
HbA1C
5.40 >>>
0.0 - 6.0
das
3:
-Fase
14.7folicular
Ciclo
Medio
: 5.82 -a
21
IgE
10.24 >>>
0
1
ao
0.0
15.0;
1
-3
5 a UI/mL
ND - 84;
Periovulatorio
Perimenstrual
8 d.- 9.0
:
Fase
Ltea
: 1.2
PRL
12.59 pool prolactina dias:
Hombres:
2.7
16.9;
Mujere
ng/mL
34
400;
Fase
Lutea:
ND - 12.0
Postmenopasicas
:
E2
58.46 >>>
27
- 246
pg/mL
Postmenopasicas
:
21.7
- 153
LH
5.33 >>>
11.3-39.8 orales
Anticoncep.
:ND mIU/mL
FSH
8.54 >>>
mIU/mL
T3T
2.06 >>>
1.30 - 2.6
nmol/L
T4T
9.48 >>>
4.80 - 12.7
g/dL
FOSFORO
4.20 >>>
2.5 - 5.6
mg/dL
FR_NFL
2.13 >>>
0.0 - 6.0
IU/L
PCR_NFL
6.70 >>>
0.0 - 10.0
mg/L
TBIL
0.89 >>>
0.0 - 1.0
mg/dL
DBIL
0.24 >>>
0.0 - 0.2
mg/dL
IBIL
0.65 >>>
0.0 - 0.8
mg/dL
T3L
3.05 >>>
1.8 - 4.2
pg/mL
TBIL
1.04 >>>
0.0 - 1.0
mg/dL
DBIL
0.37 >>>
0.0 - 0.2
mg/dL
IBIL
0.67 >>>
0.0 - 0.8
mg/dL
(Na+)
143 >>>
135.0 - 148.0
mmol/L
(K+)
4.5 >>>
3.5 - 5.3
mmol/L
(Cl-)
107 >>>
98.0 - 106.0
mmol/L
CHLAM_G
14.32 >>>
No Reactivo: < 9.0; Indeter COI
CHLAM_M
4.3 >>>
No Reactivo: < 9.0; Indeter COI
CPKTOTAL
69.34
60.0 - 219
U/L
DHL
355.10 >>>
200 - 480
U/L
WALER ROSSE
12.80 >>>
0.0 - 32.0
IU/mL
ANA
NEGATIVO
OBSERV. Metodo
NEGATIVO < 1/100; POSITIV>>>
TBIL
0.58 >>>
0.0 - 1.0
mg/dL
DBIL
0.07 >>>
0.0 - 0.2
mg/dL
IBIL
0.51 >>>
0.0 - 0.8
mg/dL
T3T
2.01 >>>
1.30 - 2.6
nmol/L
11/3/2014
11/3/2014
11/3/2014
11/3/2014
11/3/2014
11/3/2014
11/3/2014
11/3/2014
11/3/2014
11/3/2014
11/3/2014
11/3/2014
11/3/2014
11/3/2014
11/3/2014
11/3/2014
11/3/2014
11/3/2014
11/3/2014
11/3/2014
11/3/2014
11/3/2014
11/3/2014
11/3/2014
11/3/2014
11/3/2014
11/3/2014
11/3/2014
11/3/2014
11/3/2014
11/3/2014
11/3/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/4/2014
11/5/2014
11/5/2014
11/5/2014
11/5/2014
11/5/2014
11/5/2014
11/5/2014
11/5/2014
11/5/2014
11/5/2014
11/5/2014
11/5/2014
11/5/2014
11/5/2014
11/5/2014
11/5/2014
11/5/2014
11/5/2014
11/5/2014
11/5/2014
7
8
8
8
8
8
8
8
8
9
9
9
10
11
12
12
12
13
14
15
16
17
17
18
18
18
19
19
19
20
20
21
21
21
22
35
611
611
611
611
611
611
611
611
3011
3011
3011
609
24
14
14
14
1002
604
600
2
4
4
10
10
10
3021
3021
3021
408
408
401
401
401
417
86
73
73
73
73
73
73
73
73
54
54
54
14
75
65
65
65
55
31
41
18
62
62
54
54
54
87
87
87
T4T
TBIL
DBIL
IBIL
T3T
T4T
HP_G
HP_M
PCR_NFL
TBIL
DBIL
IBIL
IgE
FOSFORO
FOSFORO
FR_NFL
PCR_NFL
HbA1C
HbA1C
INS
FR_NFL
T3T
T4T
TBIL
DBIL
IBIL
TBIL
DBIL
IBIL
AFP
CEA
TBIL
DBIL
IBIL
HbA1C
8.70
0.63
0.10
0.53
1.83
7.10
14.30
7.80
34.20
0.49
0.07
0.42
78.70
4.87
3.40
2.40
6.72
5.50
5.10
17.4
2.73
1.93
6.54
0.38
0.07
0.31
0.24
0.06
0.18
3.57
6.16
0.54
0.11
0.43
10.70
>>>
4.80 - 12.7
g/dL
>>>
0.0 - 1.0
mg/dL
>>>
0.0 - 0.2
mg/dL
NEGATIVO: 00.0 - 13.0;
>>>
0.0 - 0.8
mg/dL
INDETERMINADO:
13.0 NEGATIVO:
00.0 - 13.0;
>>>
1.30
2.6
nmol/L
20.0;-POSITIVO:
20.0
INDETERMINADO:
13.0- >>>
4.80
12.7
g/dL
50.0;
FUERTE:
20.0;-POSITIVO
POSITIVO:
20.0 >>>
MayorPOSITIVO
de 50.0 FUERTE:
uIU/mL
50.0;
>>>
Mayor de 50.0
uIU/mL
>>>
0.0 - 10.0
mg/L
>>>
0.0 - 1.0
mg/dL
>>>
0.0 - 0.2
mg/dL
>>>
0.0 - 0.8
mg/dL
>>>
0 - 1 ao 0.0 - 15.0; 1 - 5 a UI/mL
>>>
2.5 - 5.6
mg/dL
>>>
2.5 - 5.6
mg/dL
>>>
0.0 - 6.0
IU/L
>>>
0.0 - 10.0
mg/L
>>>
0.0 - 6.0
%
>>>
0.0 - 6.0
%
OBSERV. BASAL2.6 - 24.9
uU/ml
>>>
0.0 - 6.0
IU/L
>>>
1.30 - 2.6
nmol/L
>>>
4.80 - 12.7
g/dL
>>>
0.0 - 1.0
mg/dL
>>>
0.0 - 0.2
mg/dL
>>>
0.0 - 0.8
mg/dL
>>>
0.0 - 1.0
mg/dL
>>>
0.0 - 0.2
mg/dL
>>>
0.0 - 0.8
mg/dL
>>>
0,0 5,5
IU/mL
>>>
No fumadores 0 - 5; fumadong/mL
>>>
0.0 - 1.0
mg/dL
>>>
0.0 - 0.2
mg/dL
>>>
0.0 - 0.8
mg/dL
>>>
0.0 - 6.0
%
11/5/2014
11/5/2014
11/5/2014
11/5/2014
11/5/2014
11/5/2014
11/5/2014
11/5/2014
11/5/2014
11/5/2014
11/5/2014
11/5/2014
11/5/2014
11/5/2014
11/5/2014
11/5/2014
11/5/2014
11/5/2014
11/5/2014
11/5/2014
11/5/2014
11/5/2014
11/5/2014
11/5/2014
11/5/2014
11/5/2014
11/5/2014
11/5/2014
11/5/2014
11/5/2014
11/5/2014
11/5/2014
11/5/2014
11/5/2014
11/5/2014